Feasibility of the novel vascular disrupting agent C118P for facilitating high-intensity focused ultrasound ablation of uterine fibroids

Yue Lia Shanghai Key Laboratory of Molecular Imaging, Jiading District Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai, China

https://orcid.org/0000-0002-4703-1651 View further author information

Jinyong Zhanga Shanghai Key Laboratory of Molecular Imaging, Jiading District Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai, ChinaView further author information

Changlian Lua Shanghai Key Laboratory of Molecular Imaging, Jiading District Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai, ChinaView further author information

Mingrui Guob School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai, ChinaView further author information

Jue Zhangc College of Medical Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, ChinaView further author information

Gang Huanga Shanghai Key Laboratory of Molecular Imaging, Jiading District Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai, ChinaCorrespondence[email protected]
View further author information

Yicheng Nid Department of Imaging & Pathology, Biomedical Sciences Group, Leuven, BelgiumCorrespondence[email protected]
View further author information

Yini Chene Department of Ultrasound in Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicinel, Shanghai, China;f Shanghai Institute of Ultrasound in Medicine, Shanghai, ChinaCorrespondence[email protected]
View further author information

show all

Feasibility of the novel vascular disrupting agent C118P for facilitating high-intensity focused ultrasound ablation of uterine fibroids

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Feasibility of the novel vascular disrupting agent C118P for facilitating high-intensity focused ultrasound ablation of uterine fibroids

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date